pharma_media1_thumb15.jpg bioMérieux, a world leader in in vitro diagnostics, launches sterility media bottles in a new format, the Clean Room Range, for ultimate quality and ease of use in final product testing of sterile pharmaceutical compounds.
bioMérieux Delivers New Clean Room Range for Sterility Testing
bioMérieux Receives FDA Clearance for Expanded Claims with VIDAS® C. difficile Toxin A&B, Enhancing Testing Solutions for Hospital Infection Control
VIDAS® offers the only fully automated test for C. difficile Toxin A&B.
bioMérieux to Reveal the Latest Food Safety Technology at the International Association of Food Protection Annual Meeting
Seventh Annual Symposium to cover food-borne outbreaks including Salmonella and E. coli O157:H7.
bioMérieux Unveils Groundbreaking E. coli O157:H7 Detection Technology at Food Safety Meeting (IAFP*)
VIDAS® UP Recombinant Phage Technology Delivers Unprecedented Level
U.S. Clinicians Indicate a Strong Need for New Tools to Combat Sepsis
Survey shows hospital physicians, pulmonary and critical care clinicians, and researchers also concerned about overuse of antibiotics.
bioMérieux Unveils Extended Menu for the VIDAS UP Platform at the American Association for Clinical Chemistry's 2008 Annual Meeting
bioMérieux providing high medical-value tests such as Procalcitonin, Cardiovascular Critical Care Range and CDA+B.
bioMérieux - First-Half 2008 Review
bioMérieux, a global leader in the field of in vitro diagnostics, today released its interim review for the six months ended June 30, 2008.
bioMérieux's Automated TEMPO® Range Now Covers the Major Quality Indicators with Two New Kits for the Enumeration of Staphylococcus and Lactic Acid Bacteria
sticker_stab_thumb14.jpg bioMérieux, a world leader in the field of in vitro diagnostics, is enhancing its line of food quality solutions with the launch of two new TEMPO® kits: TEMPO STA, for the enumeration of coagulase-positive staphylococci (S. aureus) and TEMPO LAB, for the enumeration of Lactic Acid Bacteria.
bioMérieux Increases its Lead in Microbiology with the Acquisition of the Swedish Diagnostics Specialist AB BIODISK
Company's Etest® will enhance bioMérieux's high medical-value offer.
Christian Bréchot Appointed to bioMérieux's Board
Professor Christian Bréchot has been appointed to the Board of Directors of bioMérieux S.A. during its Annual Shareholder’s Meeting, held on June 12th.